Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status
NCT07146282 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 165
Last updated 2025-08-28
Summary
VKA in RHD patients with MHV: our current status
Conditions
- Rheumatic Heart Disease
Sponsors & Collaborators
-
Ahmed Hassan Rostom Ibrahim
lead OTHER
Principal Investigators
-
Hamdy Shams Mohamed
-
Tarek hameed Nageeb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-30
- Primary Completion
- 2027-09-30
- Completion
- 2027-10-31
More Related Trials
-
Treatment of Concomitant Mitral Regurgitation by Mitral Valve Clipping in Patients With Successful Transcatheter Aortic Valve Implantation.
NCT04009434 ·Status: UNKNOWN ·Phase: NA
-
Children and Adolescents Receiving Mechanical and Prosthetic Valves
NCT00268008 ·Status: TERMINATED
-
Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia
NCT01185912 ·Status: COMPLETED
-
Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease
NCT05064514 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Papillary Muscle Approximation Provide Stability of Mitral Valve Repair for Ischemic Mitral Regurgitation
NCT03038204 ·Status: UNKNOWN
-
Comparison of Blood and Crystalloid Cardioplegia
NCT01941420 ·Status: COMPLETED
-
Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease
NCT04780607 ·Status: UNKNOWN
-
Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
NCT05774691 ·Status: COMPLETED ·Phase: PHASE4
-
Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation
NCT04141683 ·Status: UNKNOWN
-
Antagonization of Heparin With Protamine Sulfate After TAVI
NCT06215378 ·Status: RECRUITING ·Phase: PHASE3
-
Minimally Invasive Rheumatic Mitral Valve Surgery
NCT05270590 ·Status: NOT_YET_RECRUITING
-
Prognostic Values of Coronary Microvascular Dysfunction Patients Treated with Rotational Atherectomy During Percutaneous Coronary Intervention
NCT06702748 ·Status: ACTIVE_NOT_RECRUITING
-
Sodium Creatine Phosphate in Heart Valve Surgery
NCT03186053 ·Status: UNKNOWN ·Phase: NA
-
Regression of Myocardial Fibrosis After Aortic Valve Replacement
NCT02174471 ·Status: COMPLETED
-
Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve.
NCT02128841 ·Status: TERMINATED ·Phase: PHASE2
-
Left Atrial Distensibility Guiding Management in Advanced Chronic Heart Failure
NCT01307722 ·Status: UNKNOWN ·Phase: NA
-
Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair
NCT04200378 ·Status: COMPLETED
-
Cardioprotective Effect of RIPC in Patients Undergoing TAVI
NCT02283398 ·Status: WITHDRAWN ·Phase: NA
-
Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease
NCT02173860 ·Status: UNKNOWN ·Phase: NA
-
Comparative Study Between Conventional Crystalloid Cardioplegic Solution With Modified Del Nido Cardioplegia
NCT05797090 ·Status: COMPLETED ·Phase: NA
-
German Registry for Transcatheter Tricuspid Valve Interventions
NCT04653428 ·Status: RECRUITING
-
Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)
NCT05373108 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanisms of Excess Risk in Aortic Stenosis
NCT04627987 ·Status: RECRUITING
-
Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis
NCT05326126 ·Status: COMPLETED ·Phase: NA
-
Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects
NCT07040579 ·Status: NOT_YET_RECRUITING